A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

NCT06206720 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infection

Interventions

DRUG: Deuremidevir Hydrobromide for Suspension
DRUG: Placebo

Sponsor

Vigonvita Life Sciences